Socioeconomic aspects of neglected tropical diseases (Q28271639)

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Leishmaniasis and poverty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The Lancet's chronic diseases series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Rescuing the bottom billion through control of neglected tropical diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Stigma: the stealth weapon of the NTD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Stigma and the social burden of neglected tropical diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The real and the nominal? Making inflationary adjustments to cost and other economic data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Reconsidering the underestimated burden caused by neglected tropical diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The unacknowledged impact of chronic schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Schistosomiasis control: experiences and lessons from China.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The costs of preventing and treating chagas disease in Colombia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Control of onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Priority setting and the 'neglected' tropical diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Assessing the macroeconomic impact of a healthcare problem: The application of computable general equilibrium analysis to antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Household catastrophic health expenditure: a multicountry analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Equity and health sector reforms: can low-income countries escape the medical poverty trap?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

"It is me who endures but my family that suffers": social isolation as a consequence of the household cost burden of Buruli ulcer free of charge hospital treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The antipoverty vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Intestinal helminth infections, anaemia and labour productivity of female tea pluckers in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Economic effects of echinococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Economic burden of dengue infections in India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Economic effects of echinococcosis in a disease-endemic region of the Tibetan Plateau.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Economic evaluation of Mectizan distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Worms: Identifying Impacts on Education and Health in the Presence of Treatment Externalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Global burden of trachoma and economics of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Household strategies to cope with the economic costs of illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The impact of HIV and AIDS on Africa's economic development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The economic burden of malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

"Neglected" diseases but unrecognised successes--challenges and opportunities for infectious disease control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Evidence for an association between hookworm infection and cognitive function in Indonesian school children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Disease and Development: Evidence from Hookworm Eradication in the American South

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Coverage and costs of a school deworming programme in 2007 targeting all primary schools in Lao PDR.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Financial costs of deworming children in all primary schools in Cambodia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Cost containment in a school deworming programme targeting over 2.7 million children in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

National mass drug administration costs for lymphatic filariasis elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Achieving the Millennium Development Goals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

"Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Malaria control needs mass distribution of insecticidal bednets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Advancement of global health: key messages from the Disease Control Priorities Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Improving the health of the global poor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Cost effectiveness analysis of strategies to combat malaria in developing countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The control of schistosomiasis and soil-transmitted helminths in East Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Defining the cost of the Egyptian lymphatic filariasis elimination programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Combating the "other diseases" of MDG 6: changing the paradigm to achieve equity and poverty reduction?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

A cost function for HIV prevention services: is there a 'u' - shape?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The achievements and challenges of the African Programme for Onchocerciasis Control (APOC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The future of onchocerciasis control in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The African Programme for Onchocerciasis Control (APOC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Are vaccination sites in Bangladesh scale efficient?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Neglected tropical diseases and the Global Fund

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Africa's 32 cents solution for HIV/AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Public-private partnerships in blindness prevention: reaching beyond the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Deworming and development: asking the right questions, asking the questions right.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Projected benefits from integrating NTD programs in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Fighting tropical diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Successful integration of insecticide-treated bed net distribution with mass drug administration in Central Nigeria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

Prevalence of urinary schistosomiasis and HIV in females living in a rural community of Zimbabwe: does age matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021

HIV/AIDS, schistosomiasis, and girls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961422-7

7 January 2021